Get started
Author

Koji Kurokawa

Observed name: K. Kurokawa
Observed institutions: Kanazawa University, Kanazawa Medical Center, Kanazawa University Hospital, Kanazawa Municipal Hospital, Ishikawa Prefectural Central Hospital, National Hospital Organization
ORCID: 0009-0001-7991-2808
Observed ORCID: 0009-0001-7991-2808
OpenAlex ID: A5074825680
Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma
2013 · Satoshi Watanabe, Takashi Sone, et al. · Lung Cancer · 91
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
2019 · Hideharu Kimura, Tomoyuki Araya, et al. · 癌症：英文版 · 31
PDF
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune
2023 · Tsuyoshi Oguma, Takashi Ishiguro, et al. · Clinical and Translational Allergy · 27
PDF
Simultaneous occurrence of autoimmune pancreatitis and sclerosing cholangitis as immune-related adverse events of pembrolizumab
2021 · Tsuyoshi Suda, Masako Kobayashi, et al. · BMJ Case Reports · 19
Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study
2019 · Tomoyuki Araya, Toshiyuki Kita, et al. · Canadian Respiratory Journal · 9
PDF
An effective case of bronchoscopic balloon dilatation for tuberculous bronchial stenosis
2023 · Yukari Ichikawa, Koji Kurokawa, et al. · Respirology Case Reports · 5
PDF
Postoperative Recurrence of Anaplastic Lymphoma Kinase (ALK)-positive Lung Adenocarcinoma After 11 Years
2018 · Taisuke Isono, Mizuki Yuasa, et al. · Haigan · 4
PDF
Significance of EGFR and KRAS gene mutation in small cell lung cancer.
2013 · Koji Kurokawa, Tomoharu Matsui, et al. · Journal of Clinical Oncology · 4
A retrospective analysis of the efficacy of immune checkpoint inhibitors (ICIs) to advanced non-small cell cancer (NSCLC) patients (pts) with central nerve system (CNS) metastasis.
2018 · Takashi Sone, Kazuo Kasahara, et al. · Journal of Clinical Oncology · 2
Analysis of c-Met gene amplification in Japanese patients with advanced non-small cell lung cancer (NSCLC).
2011 · T. Sone, K. Kasahara, et al. · Journal of Clinical Oncology · 2
A Phase II study to evaluate the efficacy of erlotinib in advanced NSCLC patients who have wild-type EGFR and EGFR gene amplification.
2015 · Takashi Sone, Tomoyuki Araya, et al. · Journal of Clinical Oncology · 1
[The current status of nausea, vomiting and food intake in outpatients with cancer chemotherapy].
2011 · Koichi Nishi, Koji Kurokawa, et al. · PubMed · 1
Inhaled N ‐Acetylcysteine as a Potential Adjunctive Therapy in Mucus Plug‐Forming Asthma With Irpex lacteus Isolation: A Case Report
2026 · Yuka Uchida, Yusuke Hirao, et al. · Respirology Case Reports
Retrospective analysis of prognostic factors in non-small cell lung cancer with EGFR mutations.
2014 · Shingo Nishikawa, Takashi Sone, et al. · Journal of Clinical Oncology
EGFR-TKI after disease progression with central nervous system metastasis in advanced non-small cell lung cancer with EGFR mutations.
2013 · Takashi Sone, Kazuo Kasahara, et al. · Journal of Clinical Oncology
Prognostic Impact of C-MET/phospho-MET and Topoisomerase I in Small-Cell Lung Cancer
2012 · H. Ikeda, K. Kasahara, et al. · Annals of Oncology
Prognostic impact of c-Met/phospho-Met, and topoisomerase I in small cell lung cancer.
2012 · Hideko Ikeda, Hayato Koba, et al. · Journal of Clinical Oncology
Works count: 17
Citation count: 196
H-index: 5
I10-index: 4
Year
Topic
Type